What Comes After Discovery? Extending Scientific Compute Strategy Across Development and Operations
Discuss how pharma organizations are broadening compute strategy from research into development, technical operations and enterprise deployment.
Compare where infrastructure priorities stay the same and where they change across the pipeline.
Define what a joined-up scientific compute strategy looks like when AI is expected to deliver impact beyond early discovery.